Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel T Chang

Showing results (211-220 of 224) with videos related to

Pageof 23
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 30, 2020
Insulin-Like Growth Factor-1 Receptor Expression and Disease Recurrence and Survival in Patients with Resected Pancreatic Ductal AdenocarcinomaChunxia Du, Annacarolina da Silva, Vicente Morales-Oyarvide, et al.
Cell|April 19, 2020
Endocrine-Exocrine Signaling Drives Obesity-Associated Pancreatic Ductal AdenocarcinomaKatherine Minjee Chung, Jaffarguriqbal Singh, Lauren Lawres, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2020
Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic CancerSara A Väyrynen, Jinming Zhang, Chen Yuan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 9, 2019
Guidelines Insights: Hepatobiliary Cancers, Version 2.2019Al B Benson, Michael I D'Angelica, Daniel E Abbott, et al.
JCO Precision Oncology|April 20, 2023
Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2-Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid CorrelatesDaniel A King, Amber R Smith, Gino Pineda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2022
Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic CancerAndressa Dias Costa, Sara A Väyrynen, Akhil Chawla, et al.
British Journal of Cancer|October 6, 2017
Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survivalVicente Morales-Oyarvide, Douglas A Rubinson, Richard F Dunne, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 24, 2021
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyAl B Benson, Michael I D'Angelica, Daniel E Abbott, et al.
JCI Insight|September 17, 2024
SLC4A11 mediates ammonia import and promotes cancer stemness in hepatocellular carcinomaAmeer L Elaimy, Marwa O El-Derany, Jadyn James, et al.
Practical Radiation Oncology|March 28, 2025
Erratum to: Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus. Yanagihara TK, Tepper JE, Moon AM, et al. Pract Radiat Oncol. 2024 Mar-Apr;14(2):134-145Ted K Yanagihara, Joel E Tepper, Andrew M Moon, et al.
Pageof 23

Showing results (211-220 of 224) with videos related to

Sort By:
Pageof 23
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 30, 2020
Insulin-Like Growth Factor-1 Receptor Expression and Disease Recurrence and Survival in Patients with Resected Pancreatic Ductal AdenocarcinomaChunxia Du, Annacarolina da Silva, Vicente Morales-Oyarvide, et al.
Cell|April 19, 2020
Endocrine-Exocrine Signaling Drives Obesity-Associated Pancreatic Ductal AdenocarcinomaKatherine Minjee Chung, Jaffarguriqbal Singh, Lauren Lawres, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2020
Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic CancerSara A Väyrynen, Jinming Zhang, Chen Yuan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 9, 2019
Guidelines Insights: Hepatobiliary Cancers, Version 2.2019Al B Benson, Michael I D'Angelica, Daniel E Abbott, et al.
JCO Precision Oncology|April 20, 2023
Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2-Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid CorrelatesDaniel A King, Amber R Smith, Gino Pineda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2022
Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic CancerAndressa Dias Costa, Sara A Väyrynen, Akhil Chawla, et al.
British Journal of Cancer|October 6, 2017
Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survivalVicente Morales-Oyarvide, Douglas A Rubinson, Richard F Dunne, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 24, 2021
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyAl B Benson, Michael I D'Angelica, Daniel E Abbott, et al.
JCI Insight|September 17, 2024
SLC4A11 mediates ammonia import and promotes cancer stemness in hepatocellular carcinomaAmeer L Elaimy, Marwa O El-Derany, Jadyn James, et al.
Practical Radiation Oncology|March 28, 2025
Erratum to: Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus. Yanagihara TK, Tepper JE, Moon AM, et al. Pract Radiat Oncol. 2024 Mar-Apr;14(2):134-145Ted K Yanagihara, Joel E Tepper, Andrew M Moon, et al.
Pageof 23